VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 187 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50 | -21.9% | 11,684 | +20.2% | 0.00% | – |
Q2 2023 | $64 | +255.6% | 9,718 | +263.0% | 0.00% | – |
Q1 2023 | $18 | -33.3% | 2,677 | -27.1% | 0.00% | – |
Q4 2022 | $27 | -99.9% | 3,672 | 0.0% | 0.00% | – |
Q3 2022 | $36,000 | -10.0% | 3,672 | 0.0% | 0.00% | – |
Q2 2022 | $40,000 | -2.4% | 3,672 | 0.0% | 0.00% | – |
Q1 2022 | $41,000 | -29.3% | 3,672 | -0.8% | 0.00% | – |
Q4 2021 | $58,000 | +5.5% | 3,700 | +14.9% | 0.00% | – |
Q3 2021 | $55,000 | -27.6% | 3,219 | -9.2% | 0.00% | – |
Q2 2021 | $76,000 | +43.4% | 3,547 | 0.0% | 0.00% | – |
Q1 2021 | $53,000 | +60.6% | 3,547 | +37.3% | 0.00% | – |
Q4 2020 | $33,000 | +371.4% | 2,584 | +231.7% | 0.00% | – |
Q3 2020 | $7,000 | -82.9% | 779 | -78.4% | 0.00% | – |
Q2 2020 | $41,000 | -40.6% | 3,601 | -46.0% | 0.00% | – |
Q1 2020 | $69,000 | +40.8% | 6,663 | +122.1% | 0.00% | – |
Q4 2019 | $49,000 | +188.2% | 3,000 | +131.5% | 0.00% | – |
Q3 2019 | $17,000 | – | 1,296 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |